Annual EBITDA
-$15.56 M
-$7.35 M-89.41%
31 December 2023
Summary:
Immix Biopharma annual earnings before interest, taxes, depreciation & amortization is currently -$15.56 million, with the most recent change of -$7.35 million (-89.41%) on 31 December 2023. During the last 3 years, it has fallen by -$14.54 million (-1416.92%). IMMX annual EBITDA is now -1750.17% below its all-time high of -$841.20 thousand, reached on 31 December 2019.IMMX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.37 M
-$2.69 M-57.52%
30 September 2024
Summary:
Immix Biopharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.37 million, with the most recent change of -$2.69 million (-57.52%) on 30 September 2024. Over the past year, it has dropped by -$2.85 million (-62.94%). IMMX quarterly EBITDA is now -8033.55% below its all-time high of -$90.60 thousand, reached on 30 September 2020.IMMX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$22.41 M
-$2.85 M-14.55%
30 September 2024
Summary:
Immix Biopharma TTM earnings before interest, taxes, depreciation & amortization is currently -$22.41 million, with the most recent change of -$2.85 million (-14.55%) on 30 September 2024. Over the past year, it has dropped by -$7.86 million (-53.98%). IMMX TTM EBITDA is now -24639.85% below its all-time high of -$90.60 thousand, reached on 30 September 2020.IMMX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMMX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.4% | -62.9% | -54.0% |
| 3 y3 years | -1416.9% | -2021.2% | -912.0% |
| 5 y5 years | - | - | - |
IMMX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1416.9% | +35.7% | -2021.2% | +67.5% | -912.0% | +17.4% |
| 5 y | 5 years | -1750.2% | +35.7% | -8033.6% | +67.5% | <-9999.0% | +17.4% |
| alltime | all time | -1750.2% | +35.7% | -8033.6% | +67.5% | <-9999.0% | +17.4% |
Immix Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.37 M(+57.5%) | -$22.41 M(+14.5%) |
| June 2024 | - | -$4.68 M(-16.0%) | -$19.57 M(+5.1%) |
| Mar 2024 | - | -$5.57 M(+15.9%) | -$18.61 M(+19.6%) |
| Dec 2023 | -$15.56 M(+89.4%) | -$4.80 M(+6.2%) | -$15.56 M(+6.9%) |
| Sept 2023 | - | -$4.52 M(+21.6%) | -$14.56 M(+25.8%) |
| June 2023 | - | -$3.72 M(+47.6%) | -$11.57 M(+23.0%) |
| Mar 2023 | - | -$2.52 M(-33.6%) | -$9.41 M(+14.5%) |
| Dec 2022 | -$8.22 M | -$3.79 M(+147.5%) | -$8.22 M(-69.7%) |
| Sept 2022 | - | -$1.53 M(-1.8%) | -$27.13 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$1.56 M(+17.4%) | -$25.95 M(+5.7%) |
| Mar 2022 | - | -$1.33 M(-94.1%) | -$24.54 M(+1.4%) |
| Dec 2021 | -$24.20 M(+2258.2%) | -$22.71 M(+6436.8%) | -$24.20 M(+992.4%) |
| Sept 2021 | - | -$347.40 K(+127.8%) | -$2.21 M(+13.1%) |
| June 2021 | - | -$152.50 K(-84.5%) | -$1.96 M(+8.4%) |
| Mar 2021 | - | -$986.90 K(+35.6%) | -$1.81 M(+120.6%) |
| Dec 2020 | -$1.03 M(+22.0%) | -$728.00 K(+703.5%) | -$818.60 K(+803.5%) |
| Sept 2020 | - | -$90.60 K | -$90.60 K |
| Dec 2019 | -$841.20 K | - | - |
FAQ
- What is Immix Biopharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Immix Biopharma?
- What is Immix Biopharma annual EBITDA year-on-year change?
- What is Immix Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Immix Biopharma?
- What is Immix Biopharma quarterly EBITDA year-on-year change?
- What is Immix Biopharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Immix Biopharma?
- What is Immix Biopharma TTM EBITDA year-on-year change?
What is Immix Biopharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IMMX is -$15.56 M
What is the all time high annual EBITDA for Immix Biopharma?
Immix Biopharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$841.20 K
What is Immix Biopharma annual EBITDA year-on-year change?
Over the past year, IMMX annual earnings before interest, taxes, depreciation & amortization has changed by -$7.35 M (-89.41%)
What is Immix Biopharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IMMX is -$7.37 M
What is the all time high quarterly EBITDA for Immix Biopharma?
Immix Biopharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$90.60 K
What is Immix Biopharma quarterly EBITDA year-on-year change?
Over the past year, IMMX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.85 M (-62.94%)
What is Immix Biopharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IMMX is -$22.41 M
What is the all time high TTM EBITDA for Immix Biopharma?
Immix Biopharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$90.60 K
What is Immix Biopharma TTM EBITDA year-on-year change?
Over the past year, IMMX TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.86 M (-53.98%)